ganaxolone
Sign in to saveGanaxolone, sold under the brand name Ztalmy, is a medication used to treat seizures in people with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder. Ganaxolone is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 444273990
- Drug.image
- Ganaxolone.svg
- Drug.image_class
- skin-invert-image
- Drug.width
- 235
- Drug.tradename
- Ztalmy
- Drug.DailyMedID
- Ganaxolone
- Drug.routes_of_administration
- By mouth
- Drug.class
- Neurosteroid
- Drug.ATC_prefix
- N03
- Drug.ATC_suffix
- AX27
- Drug.legal_US
- Schedule V
- Drug.legal_EU
- Rx-only
- Drug.CAS_number
- 38398-32-2
- Drug.PubChem
- 6918305
- Drug.DrugBank
- DB05087
- Drug.ChemSpiderID
- 5293511
via Wikipedia infobox
~3 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- Pharmacology
- Mechanism of action
- Chemistry
- History
- References
- External links
Ganaxolone, sold under the brand name Ztalmy, is a medication used to treat seizures in people with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder. Ganaxolone is a neuroactive steroid gamma-aminobutyric acid (GABA) A receptor positive modulator.
The most common side effects of treatment with ganaxolone include somnolence (sleepiness), fever, excessive saliva or drooling, and seasonal allergy.
Excerpted from Wikipedia’s “ganaxolone” article, available under the CC BY-SA 4.0 licence.
Available in 11 languages
via Wikidata sitelinks · CC0